![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TTLL3 |
Gene summary for TTLL3 |
![]() |
Gene information | Species | Human | Gene symbol | TTLL3 | Gene ID | 26140 |
Gene name | tubulin tyrosine ligase like 3 | |
Gene Alias | HOTTL | |
Cytomap | 3p25.3 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | J3KQB2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
26140 | TTLL3 | HTA11_3410_2000001011 | Human | Colorectum | AD | 1.14e-03 | 2.21e-01 | 0.0155 |
26140 | TTLL3 | HTA11_1938_2000001011 | Human | Colorectum | AD | 2.01e-04 | 2.91e-01 | -0.0811 |
26140 | TTLL3 | HTA11_78_2000001011 | Human | Colorectum | AD | 2.57e-10 | 4.49e-01 | -0.1088 |
26140 | TTLL3 | HTA11_347_2000001011 | Human | Colorectum | AD | 2.41e-10 | 3.35e-01 | -0.1954 |
26140 | TTLL3 | HTA11_3361_2000001011 | Human | Colorectum | AD | 4.08e-04 | 3.31e-01 | -0.1207 |
26140 | TTLL3 | HTA11_696_2000001011 | Human | Colorectum | AD | 7.36e-13 | 3.79e-01 | -0.1464 |
26140 | TTLL3 | HTA11_866_2000001011 | Human | Colorectum | AD | 7.00e-24 | 6.29e-01 | -0.1001 |
26140 | TTLL3 | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.15e-14 | 4.95e-01 | -0.059 |
26140 | TTLL3 | HTA11_866_3004761011 | Human | Colorectum | AD | 4.19e-08 | 2.96e-01 | 0.096 |
26140 | TTLL3 | HTA11_10623_2000001011 | Human | Colorectum | AD | 4.32e-02 | 3.04e-01 | -0.0177 |
26140 | TTLL3 | HTA11_10711_2000001011 | Human | Colorectum | AD | 2.71e-10 | 4.66e-01 | 0.0338 |
26140 | TTLL3 | HTA11_7696_3000711011 | Human | Colorectum | AD | 1.64e-15 | 4.22e-01 | 0.0674 |
26140 | TTLL3 | HTA11_6818_2000001011 | Human | Colorectum | AD | 2.73e-08 | 5.29e-01 | 0.0112 |
26140 | TTLL3 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 2.68e-04 | 2.14e-01 | 0.294 |
26140 | TTLL3 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 1.34e-09 | 4.44e-01 | 0.281 |
26140 | TTLL3 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 2.36e-09 | 3.45e-01 | 0.3859 |
26140 | TTLL3 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 2.77e-03 | 3.62e-01 | 0.2585 |
26140 | TTLL3 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 1.57e-20 | 4.90e-01 | 0.3005 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TTLL3 | SNV | Missense_Mutation | c.861G>T | p.Glu287Asp | p.E287D | protein_coding | tolerated(0.47) | benign(0.108) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD | ||
TTLL3 | SNV | Missense_Mutation | c.1870N>A | p.Ala624Thr | p.A624T | protein_coding | tolerated(0.13) | benign(0.086) | TCGA-D1-A17D-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD | ||
TTLL3 | SNV | Missense_Mutation | novel | c.2083N>T | p.Arg695Cys | p.R695C | protein_coding | deleterious(0.02) | benign(0.049) | TCGA-DF-A2KN-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD | |
TTLL3 | SNV | Missense_Mutation | novel | c.797N>T | p.Ala266Val | p.A266V | protein_coding | tolerated(0.09) | benign(0.317) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD | |
TTLL3 | SNV | Missense_Mutation | novel | c.2317T>G | p.Phe773Val | p.F773V | protein_coding | tolerated_low_confidence(0.06) | benign(0.003) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TTLL3 | SNV | Missense_Mutation | novel | c.1536N>T | p.Lys512Asn | p.K512N | protein_coding | tolerated(0.08) | benign(0.138) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
TTLL3 | SNV | Missense_Mutation | novel | c.2608N>G | p.Phe870Val | p.F870V | protein_coding | tolerated_low_confidence(1) | benign(0) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
TTLL3 | SNV | Missense_Mutation | rs115300917 | c.697N>A | p.Asp233Asn | p.D233N | protein_coding | tolerated(0.1) | benign(0.099) | TCGA-FI-A2D0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TTLL3 | SNV | Missense_Mutation | novel | c.1409C>T | p.Pro470Leu | p.P470L | protein_coding | deleterious(0.03) | possibly_damaging(0.907) | TCGA-FI-A2D5-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatinum | PD | |
TTLL3 | SNV | Missense_Mutation | novel | c.1234N>T | p.Pro412Ser | p.P412S | protein_coding | deleterious(0.02) | probably_damaging(0.993) | TCGA-DD-AACA-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |